All Officials
Select methods...
Lobbying Records (Page 1 of 10)
2025-05-21
Politician(s) lobbied: Pádraig O'Sullivan (TD), Dáil Éireann, the Oireachtas
Intent: To highlight the importance of timely access to genetic testing for those with ATTR-CM in Ireland
Methods: Email
Details & Methods:
| Method | Description |
|---|---|
| — | Treatment of Amyloidosis and ATTR-CM M |
2025-05-21
Politician(s) lobbied: Peter Burke (Minister), Department of Enterprise, Trade and Employment; Micheál Martin (Taoiseach), Dáil Éireann, the Oireachtas; Simon Harris (Tánaiste and Minister), Department of Foreign Affairs; Jennifer Carroll MacNeill (Minister), Department of Health; Laura Mannion (Special Adviser), Department of Enterprise, Trade and Employment; Deirdre Gillane (Chief of Staff), Department of the Taoiseach; Billy Kelleher (MEP), European Parliament
Intent: Highlight negative impact of changes to the EU Pharmaceutical legislation on the Irish economy and EU competitiveness
Methods: Meeting, Email, Letter
Details & Methods:
| Method | Description |
|---|---|
| — | EU Pharmaceutical Legislation proposals |
2025-05-21
Politician(s) lobbied: Simon Harris (An Taoiseach), Department of the Taoiseach; Micheál Martin (Tánaiste and Minister), Department of Foreign Affairs; David Cullinane (TD), Dáil Éireann, the Oireachtas; Jennifer Carroll MacNeill (Minister), Department of Health; Laura Mannion (Special Adviser), Department of Enterprise, Trade and Employment; Peter Burke (Minister), Department of Enterprise, Trade and Employment; Pádraig O'Sullivan (TD), Dáil Éireann, the Oireachtas
Intent: To implement the Mazar's reimbursement review recommendations and publish the working group report ::Faster access to new medicines for patients
Methods: Email, Letter, Meeting
Details & Methods:
| Method | Description |
|---|---|
| — | Ireland's medicine reimbursement system and funding for access to new medicines and vaccines |
2025-05-21
Politician(s) lobbied: Micheál Martin (An Taoiseach), Department of the Taoiseach; Simon Harris (Tánaiste and Minister), Department of Foreign Affairs; Jennifer Carroll MacNeill (Minister), Department of Health; Peter Burke (Minister), Department of Enterprise, Trade and Employment; Laura Mannion (Special Advisor), Department of Enterprise, Trade and Employment; David Cullinane (TD), Dáil Éireann, the Oireachtas
Intent: Highlight the importance of the roll-out of an RSV National Immunisation Programme for those over 65 years old to reduce the burden of RSV disease which continues to cause illness and hospitalisation among infants and older adults. The spread of RSV is of particular concern in nursing homes and residential healthcare settings and can lead to further respiratory complications for older people. ::Expansion of the infant programme to include a maternal vaccine so that parents have the opportunity to choose between a mother receiving a vaccine during pregnancy or the newborn baby receiving a monoclonal antibody
Methods: Letter, Email
Details & Methods:
| Method | Description |
|---|---|
| — | Expansion of the National Immunisation Programme to include RSV protection for infants and older adults |
2025-05-21
Politician(s) lobbied: Micheál Martin (An Taoiseach), Department of the Taoiseach; Joanne Lonergan (Programme Manager - Tánaiste), Department of the Taoiseach; Pauric McPhillips (Special Advisor to the Tanaiste), Department of the Taoiseach; Deirdre Gillane (Chief of Staff), Department of the Taoiseach; Diarmuid Lynch (Special Adviser), Department of the Taoiseach; Paschal Donohoe (Minister), Department of Public Expenditure, NDP Delivery and Reform; Simon Harris (Tánaiste and Minister), Department of Defence; Peter Burke (Minister), Department of Enterprise, Trade and Employment; Laura Mannion (Special Advisor), Department of Enterprise, Trade and Employment; Billy Kelleher (MEP), European Parliament; Geraldine Byrne Nason (Ambassador), Department of Foreign Affairs
Intent: To highlight that tariffs on medicines and their inputs would increase healthcare costs for patients and increase the cost of producing medicines, reducing the competitiveness of pharmaceutical manufacturers that drive innovation. Globally integrated supply chains for medicines means that the impact of tariffs cannot be limited to one country. ::Ensuring pharmaceuticals are exempt from any potential retaliatory tariffs because suchmeasures have a cumulative negative impact, increasing the cost of production andreducing patient access.
Methods: Email, Phone call, Meeting
Details & Methods:
| Method | Description |
|---|---|
| — | Raise concern about the impact of potential tariffs on pharmaceutical manufacturing and supply of medicines to patients globally |
2025-01-21
Politician(s) lobbied: Seán Kelly (MEP), European Parliament
Intent: Raise awareness of the importance of a fact based assessment of the impact of banning PFAS for pharmaceutical manufacturing
Methods: Meeting
Details & Methods:
| Method | Description |
|---|---|
| — | PFAS restrictions |
2025-01-21
Politician(s) lobbied: David Cullinane (TD), Dáil Éireann, the Oireachtas; Susan Mitchell (Special Adviser), Department of Health; Niall Redmond (Assistant Secretary), Department of Health; Robert Watt (Secretary General), Department of Health; Mary Horgan (Interim Chief Medical Officer), Department of Health
Intent: Ensure progress of reimbursement application and provide information regarding clinical data with regard to proposed clinical guidance
Methods: Letter, Informal communication, Phone call
Details & Methods:
| Method | Description |
|---|---|
| — | Access to an antiviral medication for the treatment of COVID-19 |
2025-01-21
Politician(s) lobbied: Micheál Martin (Tánaiste and Minister), Department of Foreign Affairs; Simon Harris (An Taoiseach), Department of the Taoiseach; James Browne (Minister of State), Department of Justice; Jennifer Carroll MacNeill (Minister), Department of Defence; Diarmuid Lynch (Special Adviser), Department of the Taoiseach; Clare Mungovan (Special Adviser), Department of the Taoiseach; Deirdre Gillane (Chief of Staff), Department of the Taoiseach; Joanne Lonergan (Chief of Staff), Department of the Taoiseach
Intent: To ask the incoming Government to produce a comprehensive life science strategy for Ireland and maintain the state's committment to pro-industrial and pro-innovation economic policies
Methods: Email, Informal communication, Letter
Details & Methods:
| Method | Description |
|---|---|
| — | Life Science Strategy and Industrial Policy |
2025-01-21
Politician(s) lobbied: Peter Burke (Minister), Department of Enterprise, Trade and Employment; Declan Hughes (Secretary General), Department of Enterprise, Trade and Employment; Jack Chambers (Minister), Department of Finance; Helen Blake (Assistant Secretary), Department of the Taoiseach; John Shaw (Assistant Secretary), Department of the Taoiseach; Muiris O’Connor (Assistant Secretary), Department of Health
Intent: Highlight negative impact of changes to the EU Pharmaceutical legislation on the Irish economy and EU competitiveness
Methods: Meeting
Details & Methods:
| Method | Description |
|---|---|
| — | EU Pharmaceutical Legislation proposals |
2025-01-21
Politician(s) lobbied: Simon Harris (An Taoiseach), Department of the Taoiseach; Micheál Martin (Tánaiste and Minister), Department of Foreign Affairs; Stephen Donnelly (Minister), Department of Health; Jack Chambers (Minister), Department of Finance; Paschal Donohoe (Minister), Department of Public Expenditure, NDP Delivery and Reform; Deirdre Gillane (Chief of Staff), Department of the Taoiseach; Diarmuid Lynch (Special Adviser), Department of the Taoiseach; Joanne Lonergan (Chief of Staff), Department of the Taoiseach; Clare Mungovan (Special Adviser), Department of the Taoiseach; David Cullinane (TD), Dáil Éireann, the Oireachtas; Majella Fitzpatrick (Special Adviser), Department of the Taoiseach; Sam Griffin (Adviser to Minister), Department of Finance; David Cullinane (TD), Dáil Éireann, the Oireachtas; Sarah Bardon (Chief of Staff), Department of the Taoiseach; Muiris O’Connor (Assistant Secretary), Department of Health
Intent: A commitment within the Programme for Government that the Mazar's reimbursement review recommendations be implemented and that the working group report be published as soon as possible::Faster access to new medicines for patients ::Funding for new medicines in Budget 2025
Methods: Email, Letter, Meeting, Phone call, Informal communication
Details & Methods:
| Method | Description |
|---|---|
| — | Ireland's medicine reimbursement system and funding for access to new medicines and vaccines |
…